Rapid Medical Research, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Beachwood OH United States (1997)

Organization Overview

First Clinical Trial
2009
NCT01038843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dr. Lila Nachtigall | Dr. Lila Nachtigall Rapid Medical Research, New York | Rapid Medical Research | Rapid Medical Research Inc | Rapid Medical Research of New York

Active Ingredients

Drugs in Phase 3 Trials (1)

influenza vaccine, recombinant hemagglutinin (1 trial)

Drugs in Phase 2 Trials (2)

bpze1 (1 trial)

va106483 (1 trial)

Drugs in Phase 1 Trials (2)

vxa-g1.1-nn (1 trial)

vxa-g2.4-ns (1 trial)

Drugs in Other Trials (2)

flaxseed (1 trial)

soy extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Caliciviridae Infections (Phase 1)

Influenza, Human (Phase 3)

Nocturia (Phase 2)

Whooping Cough (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 7